✨ Free AI Report
Astellas Pharma Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Astellas Pharma Inc.
Research Preview

Astellas Pharma Inc.: Business Overview, Financials & Competitive Analysis

Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company is a specialty international pharmaceutical company focused on accelerating the discovery, dev...

Analyst-debate audio for Astellas Pharma Inc.

AskCyborg analysts argue the bull and bear cases for Astellas Pharma Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Astellas Pharma Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Trading at 56.1% below estimate of fair value, but faces long-term revenue headwinds from patent expirations and competitive...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing - General
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 7, 2026
AI-Verified Research
30+ Page Report

Get the Latest Astellas Pharma Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Astellas Pharma Inc. Overview

Pro stress-test →

Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company is a specialty international pharmaceutical company focused on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases.

Strategic Profile

Pro stress-test →

The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. Astellas is experiencing strong global sales trends of XTANDI for prostate cancer and BETANIS/MYRBETRIQ/BETMIGA for overactive bladder.

Competitive Landscape

Pro stress-test →

One of Astellas Pharma's 64 competitors is Novartis, a Corporation company based in Basel, Switzerland. Loss of exclusivity for major drugs and persistent R&D challenges threaten future revenue stability, while pricing pressures, regulatory risks, and supply chain complexities increase margin volatility across key global markets.

Industry Context

Astellas Pharma Inc. operates in Pharmaceutical Manufacturing - General.

Key facts

Founded: 1923 · Headquarters: Chuo, Japan · Revenue: $13.4B · Market cap: $28.9B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Astellas Pharma Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Astellas Pharma Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Gilenya/FingolimodImmunology and rare disease focus→PharmacovigilanceOncology and diagnostics leader→Oncology PortfolioLarge cap diversified pharma→Specialty PharmaNeurology and immunology specialist→

Compare Astellas Pharma Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Astellas Pharma Inc. operates in Pharmaceutical Manufacturing - General. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing - General research →
NEW · MCP server

Ask your AI assistant about Astellas Pharma Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Astellas Pharma Inc. and its top competitor on Cyborg Score”
“What did Astellas Pharma Inc. do this quarter?”
“Is Astellas Pharma Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Astellas Pharma Inc. do?+
Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company is a specialty international pharmaceutical company focused on accelerating the discovery, dev...
What is Astellas Pharma Inc.'s Cyborg Score?+
Astellas Pharma Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Astellas Pharma Inc.'s main competitors?+
Named competitors include Gilenya/Fingolimod, Pharmacovigilance, Oncology Portfolio, Specialty Pharma. The full competitive landscape is in the AskCyborg report.
How can I get the full Astellas Pharma Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Astellas Pharma Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Astellas Pharma Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.